Anemia is a condition that develops when your blood lacks enough healthy red blood cells or hemoglobin. Hemoglobin is a main part of red blood cells and binds oxygen. If you have too few or abnormal red blood cells, or your hemoglobin is abnormal or low, the cells in your body will not get enough oxygen.
Anemia is defined as a hemoglobin below two standard deviations of the mean for the age and gender of the patient. Iron is an essential component of the hemoglobin molecule. The most common cause of anemia worldwide is an iron deficiency, which results in microcytic and hypochromic red cells on the peripheral smear. Several causes of iron deficiency vary based on age, gender, and socioeconomic status. The patient often will have nonspecific complaints such as fatigue and dyspnea on exertion. Treatment is a reversal of the underlying condition as well as iron supplementation. Iron supplementation is most often oral, but certain cases may require intravenous iron. Patients with iron-deficient anemia have been found to have a longer hospital stay along with a higher number of adverse events.[rx],[rx],[rx]
Anemia occurs when either the number of red blood cells (RBCs) is too low or the hemoglobin within those cells is deficient. Hemoglobin is the protein that binds oxygen in the lungs and delivers it throughout the body. When hemoglobin levels drop below normal, tissues receive less oxygen and can’t function properly. Clinically, anemia is diagnosed when hemoglobin falls below 13.0 g/dL in men or below 12.0 g/dL in women. The condition can range from mild—where symptoms may be barely noticeable—to severe, which can cause chest pain, shortness of breath, and organ damage if left untreated.
Anemia is defined as a condition in which the number of red blood cells or the hemoglobin concentration within them is lower than normal, resulting in a reduced capacity of the blood to carry oxygen to the body’s tissues. Hemoglobin, the iron-rich protein in red blood cells, binds oxygen in the lungs and releases it throughout the body; when hemoglobin levels fall below established cut-off points, tissues receive inadequate oxygen, leading to fatigue, weakness, dizziness, and shortness of breath World Health OrganizationWorld Health Organization. The World Health Organization (WHO) specifies different hemoglobin thresholds depending on age, sex, and physiological status: at sea level, anemia is diagnosed when hemoglobin is below 130 g/L in adult men, below 120 g/L in nonpregnant women, and below 110 g/L in pregnant women and children under five World Health Organization. Anemia’s impact ranges from impaired cognitive and physical development in children to increased maternal mortality and reduced work capacity in adults, making it a major global public health concern.
Normal Hb-specific laboratory cut-offs will differ slightly, but in general, the normal ranges are as follows:
- 135 to 180 g/L in men
- 120 to 150 g/L in women
- 110 to 160 g/L in children
- Varied in pregnancy depending on the trimester, but generally greater than 100 g/L
Types of Anemia
Clinicians classify anemia first by RBC size (mean corpuscular volume, MCV), which guides the diagnostic approach:
Microcytic Anemia: Characterized by smaller-than-normal RBCs (MCV < 80 fL). It typically results from impaired hemoglobin synthesis, most often due to iron deficiency or thalassemia Healthline.
Normocytic Anemia: RBCs are normal in size (MCV 80–100 fL) but reduced in number. Causes include acute blood loss, hemolysis, and anemia of chronic disease Healthline.
Macrocytic Anemia: RBCs are larger than normal (MCV > 100 fL) due to defective DNA synthesis, as seen with vitamin B₁₂ or folate deficiencies and certain medications Healthline.
Classification by Underlying Mechanism
- Production disorders anemias: occur when the bone marrow fails to make enough red blood cells—examples include aplastic anemia and marrow infiltration.
- Destruction (hemolytic) anemias: involve prematurely destroyed red cells, seen in conditions like sickle cell disease or autoimmune hemolysis.
- Blood loss anemias: result from chronic bleeding—such as gastrointestinal ulcers or heavy menstruation—depleting red cell mass.
- Decreased RBC Production: nutritional deficiencies (iron, B₁₂, folate), bone marrow disorders (aplastic anemia, myelodysplastic syndromes), endocrine causes (chronic kidney disease with reduced erythropoietin), or chronic infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation.
- Increased RBC Destruction (Hemolysis): inherited hemoglobinopathies (sickle cell disease, thalassemia), enzyme deficiencies (G6PD deficiency), immune-mediated hemolysis, and mechanical destruction (prosthetic heart valves). Wikipedia
This morphological classification helps narrow down the underlying mechanism—whether it’s decreased production, increased destruction, or blood loss—and dictates the next steps in evaluation NCBI.
A second functional classification considers the mechanism of anemia:
Hypoproliferative Anemia: Bone marrow production is inadequate (e.g., aplastic anemia, renal disease).
Hemolytic Anemia: Premature destruction of RBCs exceeds production (e.g., hereditary spherocytosis, autoimmune hemolysis).
Hemorrhagic Anemia: Chronic or acute blood loss outpaces RBC replacement (e.g., gastrointestinal bleeding, trauma).
A to Z Types of Anemia
Below are twenty conditions that can lead to low hemoglobin. Each description is in simple language, highlighting how the disease affects Hb levels.
Iron Deficiency Anemia
Caused by insufficient iron to make hemoglobin, leading to small, pale RBCs. Common in women with heavy periods, children with poor diets, and people losing blood from the gut. Symptoms develop slowly, including fatigue and cold hands. Diagnosis involves CBC and iron studies; treatment is dietary iron and supplements Wikipedia.Sideroblastic Anemia
Cells cannot incorporate iron into heme, resulting in ringed sideroblasts visible under a microscope. This may be inherited or acquired from alcohol use, lead poisoning, or certain medications.Pernicious Anemia
An autoimmune destruction of stomach cells prevents intrinsic factor production, impairing vitamin B12 absorption. Over time, B12 deficiency leads to macrocytic anemia and neurological signs.Folate Deficiency Anemia
Inadequate folate intake or increased requirement—such as during pregnancy—disrupts DNA synthesis in red cell precursors, causing large but few red cells and moderate anemia.Hemolytic Anemia (Autoimmune)
The body’s immune system mistakenly attacks its own red cells. Warm or cold antibody variants can cause chronic red cell destruction, leading to moderate anemia and jaundice.- Leishmaniasis
A parasitic infection that invades bone marrow and spleen, impairing blood cell production and causing moderate anemia along with fever and weight loss. Aplastic Anemia
Bone marrow failure leads to reduced production of all blood cells, including RBCs. In mild cases, hemoglobin may dip slightly before pancytopenia develops. Early recognition through blood counts and prompt treatment (immunosuppression or transplant) is crucial Wikipedia.Pure Red Cell Aplasia (PRCA)
An isolated failure of RBC production—often immune‑mediated or congenital—causes gradual hemoglobin decline. Other blood lines remain normal. Mild PRCA may present with subtle anemia before transfusion dependence arises Verywell Health.- Anemia Due to Excessive Bleeding
Acute or chronic hemorrhage (trauma, GI ulcers, menorrhagia) depletes RBC mass faster than marrow can replace them. MSD Manuals - Fanconi Anemia
A hereditary marrow failure syndrome with DNA repair defects. Patients develop severe anemia in childhood alongside congenital anomalies. Wikipedia An inherited DNA repair disorder causing bone marrow failure and pancytopenia. Presents in childhood with congenital anomalies and progressive anemia. Diagnosis via chromosomal breakage tests; treatment includes bone marrow transplant Wikipedia. Post‑Hemorrhagic Anemia
Acute blood loss from trauma or surgery leads to sudden drop in Hb and hypovolemia. Presents with shock signs. Treated by stopping bleeding and transfusing blood products Wikipedia.Vitamin B₁₂ Deficiency Anemia
When the body lacks B₁₂—due to poor diet, malabsorption, or pernicious anemia—it cannot properly form DNA in RBC precursors. This leads to large, fragile RBCs (macrocytes) and low Hb. Presents with fatigue, numbness, and memory problems. Treated with injections or high‑dose oral B₁₂ Wikipedia.Folate Deficiency Anemia
Similar to B₁₂ deficiency, folate shortage impairs DNA synthesis, producing macrocytic RBCs. It can result from poor diet, alcoholism, or certain drugs. Symptoms include tiredness, mouth sores, and neural tube defects in pregnancy. Folate supplements correct the deficiency nhs.uk.Aplastic Anemia
A serious condition where bone marrow stops making enough blood cells of all types—red cells, white cells, and platelets. It can follow infections, toxins, or be idiopathic. Patients have severe fatigue, infections, and bleeding. Diagnosis is by bone marrow biopsy; treatment is immunosuppression or stem cell transplant Wikipedia.Hemolytic Anemia
RBCs are destroyed faster than the marrow can replace them. Causes include autoimmune attacks, inherited defects (e.g., G6PD deficiency), or mechanical damage. Presents with jaundice, dark urine, and enlarged spleen. Managed by treating the trigger and sometimes removing the spleen Wikipedia.Sickle Cell Anemia
An inherited hemoglobinopathy where red cells sickle under low oxygen, causing blockage in vessels and early cell breakdown. Symptoms start in childhood: pain episodes, anemia, and organ damage. Treatment includes hydration, pain control, and hydroxyurea; curative options include bone marrow transplant Wikipedia.Anemia of Chronic Disease
Long‑term inflammation from infections, autoimmune diseases, or cancer raises hepcidin levels, trapping iron and reducing RBC production. Typically normocytic, patients have mild to moderate anemia. Managing the underlying disease is key Wikipedia.Chronic Kidney Disease (CKD)–Related Anemia
Damaged kidneys produce less erythropoietin, leading to fewer RBCs. Present as normocytic anemia with fatigue and reduced exercise tolerance. Treated with erythropoiesis‑stimulating agents and iron supplementation Wikipedia.Myelodysplastic Syndrome (MDS)
A bone marrow disorder where stem cells produce abnormal blood cells that die early. Presents with cytopenias, including anemia. Risk of progression to leukemia. Diagnosis via bone marrow exam; treatment ranges from supportive care to stem cell transplant Wikipedia.- Hereditary Spherocytosis
Defects in RBC membrane proteins cause spherocytes that are prematurely destroyed by the spleen, leading to chronic hemolytic anemia and splenomegaly Wikipedia. - Hemodilutional anemia arises when plasma volume increases disproportionately (for instance in pregnancy or fluid overload), diluting red blood cells so that hemoglobin concentration falls despite normal cell size. Wikipedia
Some Key Description
1. Iron deficiency anemia
- often falls into this category. In this case, the disorder is brought on by a shortage of iron, most often caused by blood loss.
- When blood is lost, the body reacts by pulling in water from tissues outside the bloodstream in an attempt to keep the blood vessels filled. This additional water dilutes the blood, and, as a result, the red blood cells are diluted.
- Blood loss can be categorized as acute and rapid or chronic. Rapid blood loss can include surgery, childbirth, trauma, or a ruptured blood vessel.
- Chronic blood loss is more frequent among patients diagnosed with anemia. Here, the blood loss can be a result of stomach ulcers, cancer, or tumor.
- Gastrointestinal conditions – such as ulcers, hemorrhoids, cancer, or gastritis
- Use of non-steroidal anti-inflammatory drugs (NSAIDs) – such as aspirin and ibuprofen
- Menstrual bleeding
2. Anemia due to low red blood cell productions
- Located in the center of our bones is a soft, spongy tissue, called bone marrow, it is essential for the creation of red blood cells. Bone marrow produces stem cells, which develop into red blood cells, white blood cells, and platelets.
- Bone marrow can be affected by a number of diseases, including leukemia, where abnormal white blood cells are produced in excess, which disrupts normal production of red blood cells.
- Other examples of anemias caused by decreased or faulty red blood cells are:
3. Sickle cell anemia
- Red blood cells are misshapen and break down abnormally quickly. The crescent-shaped blood cells can also get stuck in smaller blood vessels, causing pain.
- Iron-deficiency anemia – not enough red blood cells are produced because not enough iron is present in the body. This can be because of a poor diet, menstruation, frequent blood donation, endurance training, certain digestive conditions, such as Crohn’s disease, surgical removal of part of the gut, and some foods.
- Bone marrow and stem cell problems – for instance, aplastic anemia occurs when there are little or no stem cells present. Thalassemia occurs when red blood cells can’t grow and mature properly.
4. Vitamin deficiency anemia
- Vitamin B-12 and folate are both essential for the production of red blood cells; therefore, if either is deficient, red blood cell production will be too low. Examples of this type of anemia are megaloblastic anemia and pernicious anemia.
5. Anemia caused by the destruction of red blood cells
- Red blood cells typically have a life span of 120 days in the bloodstream, but they can be destroyed or removed beforehand.
- One type of anemia that falls into this category is autoimmune hemolytic anemia, where the body’s immune system mistakenly identifies its own red blood cells as a foreign substance and attacks them. Excessive hemolysis (red blood cell breakdown) can occur for many reasons, including:
- Infections
- Certain drugs – some antibiotics, for instance
- Snake or spider venom
- Toxins produced through advanced kidney or liver disease
- Autoimmune attack – for instance hemolytic disease
- Severe hypertension
- Vascular grafts and prosthetic heart valves
- Clotting disorders
- Enlargement of the spleen
- There are a LOT of diseases and conditions which can lead to anemia. These diseases can be grouped together into four broad causes of having too few red blood cells (RBCs) in blood.
6. Aplastic anemia
- folic acid deficiency iron deficiency anemia kidney disease leukemia and myelodysplastic syndrome thalassemia
- pernicious anemia (vitamin B12 deficiency)
- chronic diseases (e.g. HIV, Crohn’s disease, etc…)( Increased destruction of RBCs
- glucose-6-phosphate dehydrogenase deficiency
7. Hemolytic anemia
- sickle cell anemia
- transfusion reactions , Loss of RBCs (bleeding) ,gastrointestinal ulcers
- major injuries or surgery menstruation , Dilution of RBCs (fluid overload) ,pregnancy
Causes of Anemia
Blood Loss
Acute or chronic bleeding—from trauma, surgery, ulcers, or heavy menstruation—reduces total red blood cell volume, leading to anemia when production cannot keep up.Iron Deficiency
Inadequate intake of iron-rich foods (meat, beans, leafy greens) or poor absorption in conditions like celiac disease deprives the body of the key element for hemoglobin synthesis.Vitamin B12 Deficiency
A diet lacking animal products or impaired absorption in the stomach or small intestine causes insufficient B12, disrupting red cell maturation.Folate Deficiency
Low folate intake—common in malnutrition, alcoholism, and certain drug therapies—hurts DNA synthesis in developing red blood cells.Chronic Kidney Disease
Diseased kidneys produce less erythropoietin, a hormone that signals the bone marrow to make red blood cells, leading to anemia over time.Rheumatoid Arthritis
Persistent inflammation increases hepcidin levels, trapping iron in storage sites and hindering its use for hemoglobin production (anemia of chronic disease).Autoimmune Disorders
Conditions like lupus can attack red cells directly (autoimmune hemolytic anemia) or damage bone marrow, reducing blood cell production.Bone Marrow Disorders
Aplastic anemia, myelodysplastic syndromes, leukemia, and other marrow diseases impair the production of healthy blood cells.Genetic Mutations
Inherited defects—such as sickle cell disease, thalassemia, and hereditary spherocytosis—disrupt normal hemoglobin structure or red cell membrane integrity.Infections
Certain infections (malaria, HIV, hepatitis) can directly destroy red blood cells or suppress marrow function.Medications and Toxins
Chemotherapy drugs, some antibiotics, and toxins like benzene damage bone marrow or provoke hemolysis.Nutritional Deficiencies
Severe malnutrition deprives the body of multiple vitamins and minerals needed for red cell production.Pregnancy
Increased blood volume and iron demands during pregnancy can outpace supply, causing mild anemia in many women.Gastrointestinal Disorders
Diseases like Crohn’s or ulcers lead to chronic bleeding or malabsorption of iron and vitamins.Lead Poisoning
Lead interferes with several enzymes in heme synthesis, leading to anemia, abdominal pain, and neurological symptoms.Alcohol Abuse
Alcohol damages bone marrow cells directly and can lead to poor nutrition, compounding anemia risk.Hypothyroidism
Low thyroid hormone slows metabolism and can blunt marrow activity, leading to normocytic anemia.Hemolytic Transfusion Reactions
Incompatible blood transfusions trigger rapid destruction of donor and recipient red cells, causing an acute anemia.Sheehan’s Syndrome
Postpartum pituitary gland damage reduces erythropoietin-stimulating hormones, leading to anemia in severe cases.Parasitic Infections
Hookworm and schistosomiasis consume blood or damage the intestinal lining, resulting in chronic blood loss and anemia.Folate Deficiency
Folate (vitamin B₉) is essential for thymidine synthesis in DNA. Poor dietary intake, malabsorption (celiac disease), increased requirements (pregnancy), or medications (methotrexate) can deplete folate, resulting in megaloblastic macrocytosis WikipediaMedscape.Methotrexate Therapy
Methotrexate inhibits dihydrofolate reductase, blocking folate recycling and DNA synthesis. Chronic low‐dose therapy for arthritis or high‐dose oncology regimens can precipitate megaloblastic changes Wikipedia.Trimethoprim/Sulfamethoxazole
Trimethoprim interferes with folate metabolism, while sulfamethoxazole inhibits dihydropteroate synthase in bacteria but may also affect host folate pathways. Prolonged use can lead to macrocytosis Wikipedia.Anticonvulsant Medications (Phenytoin, Valproic Acid)
These drugs can impair folate absorption or metabolism, leading to megaloblastic macrocytosis over months of therapy Wikipedia.Zidovudine (AZT)
An antiretroviral that inhibits DNA polymerase-γ in mitochondria, zidovudine can cause macrocytosis even before anemia develops, likely via direct marrow toxicity Wikipedia.Hydroxyurea
Used in myeloproliferative disorders and sickle-cell disease, hydroxyurea’s effects on DNA synthesis can yield macrocytic changes in erythroid precursors Wikipedia.
Symptoms of Anemia
Fatigue
The most common symptom, caused by reduced oxygen delivery to muscles and organs, leading to a persistent feeling of tiredness.Weakness
Muscle strength decreases when less oxygen reaches muscle tissue, making everyday tasks more difficult.Paleness (Pallor)
Reduced hemoglobin makes skin, gums, and nail beds appear unusually pale, especially in fair-skinned individuals.Shortness of Breath
Lower oxygen-carrying capacity forces the body to increase breathing rate, causing breathlessness even with mild activity.Dizziness or Lightheadedness
Inadequate oxygen supply to the brain can cause faintness or a spinning sensation, particularly when standing quickly.Cold Hands and Feet
Poor circulation and low red cell count can make extremities feel chilled, as the body prioritizes core organs.Chest Pain
Severe anemia can strain the heart, causing chest discomfort or angina-like pain, especially in those with underlying heart disease.Headache
Brain tissue deprived of oxygen may trigger headaches or migraines in some people with anemia.Difficulty Concentrating
Cognitive function requires a constant oxygen supply; reduced levels can impair attention and memory.Rapid or Irregular Heartbeat
The heart compensates for low oxygen by beating faster or more forcefully, which may be felt as palpitations.Leg Cramps
Poor oxygenation of leg muscles during activity or at night can lead to painful cramps.Restless Legs Syndrome
Some people with anemia experience an uncontrollable urge to move their legs, especially at night.Brittle Nails
Chronic anemia can affect keratin production, leading to nails that crack or split easily.Jaundice
In hemolytic anemias, rapid red cell breakdown raises bilirubin levels, causing yellowing of the skin and eyes.Sore or Smooth Tongue
Deficiencies of iron, B12, or folate can lead to glossitis—an inflamed, sore, or unusually smooth tongue.
Further Diagnostic Tests
Physical Exam Tests
Skin and Mucosal Inspection
The clinician checks for pallor in the face, palms, and under the eyelids; dark-skinned individuals may show pallor in conjunctiva or nail beds.Palpation of the Spleen
Enlargement of the spleen (splenomegaly) suggests hemolysis or certain bone marrow disorders contributing to anemia.Cardiac Auscultation
Listening for murmurs or rapid heartbeats can indicate the heart’s compensatory response to low oxygen levels.
Manual Tests
Stool Guaiac Test
A small stool sample is tested for hidden (occult) blood, helping identify gastrointestinal bleeding as a cause of anemia.Schilling Test
Measures vitamin B12 absorption by comparing urinary excretion with and without intrinsic factor, helping diagnose pernicious anemia.Osmotic Fragility Test
Red cells are placed in increasingly dilute salt solutions; cells from hereditary spherocytosis burst more easily, indicating membrane defects.Sickling Test
A drop of blood is deoxygenated in the lab; if cells sickle, it supports a diagnosis of sickle cell disease.Reticulocyte Count (Manual)
A trained technician visually counts immature red cells on a smear to gauge bone marrow response to anemia.Direct Antiglobulin (Coombs) Test
Detects antibodies attached to red cells, confirming autoimmune hemolytic anemia when positive.
Lab and Pathological Tests
Complete Blood Count (CBC)
Measures hemoglobin, hematocrit, and red cell indices (MCV, MCH, MCHC) to classify anemia as microcytic, normocytic, or macrocytic.Peripheral Blood Smear
A stained smear allows microscopy of red cell shape, size, and color—vital clues for diagnosing types like sickle cell, spherocytosis, or megaloblastic anemia.Serum Ferritin
Reflects iron stores; low ferritin is a sensitive marker for iron deficiency anemia.Serum Iron
Measures circulating iron bound to transferrin; low levels point to deficiency, while high levels can occur in hemolysis.Total Iron‑Binding Capacity (TIBC)
Indicates the blood’s capacity to bind iron; elevated in iron deficiency and low in anemia of chronic disease.Vitamin B12 Level
Low serum B12 confirms deficiency anemia; values below 200 pg/mL are diagnostic in the right clinical context.Folate (Vitamin B9) Level
Low red blood cell or serum folate levels indicate folate deficiency, a cause of macrocytic anemia.Reticulocyte Count (Automated)
Automated machines quantify young red cells to assess if the marrow is responding appropriately—high in hemolysis or bleeding, low in production defects.Lactate Dehydrogenase (LDH)
Elevated LDH suggests increased red cell destruction, as this enzyme is released from broken cells.Bilirubin (Indirect)
High levels of unconjugated bilirubin indicate hemolytic anemia, since rapid breakdown of red cells overwhelms liver processing.Haptoglobin
A protein that binds free hemoglobin; low haptoglobin levels signal hemolysis when red cells are destroyed in circulation.
Electrodiagnostic Test
Hemoglobin Electrophoresis
Uses an electric field to separate different hemoglobin types, diagnosing conditions like sickle cell disease or beta-thalassemia.Flow Cytometry for RBC Antigens
Detects cell-surface markers and antibodies, useful in autoimmune hemolytic anemia and paroxysmal nocturnal hemoglobinuria.
Imaging Tests
Abdominal Ultrasound
Visualizes the liver and spleen for enlargement or structural disease contributing to hemolysis or sequestration of red cells.Upper GI Endoscopy
Directly inspects the esophagus, stomach, and small intestine for bleeding ulcers or lesions causing chronic blood loss.Colonoscopy
Examines the colon for polyps, cancers, or inflammatory bowel disease as sources of occult bleeding and iron deficiency.Magnetic Resonance Imaging (MRI) of Bone Marrow
Assesses marrow cellularity and infiltration in disorders like aplastic anemia, myelodysplasia, or marrow fibrosis.Computed Tomography (CT) Scan
Detailed cross-sectional imaging to locate hidden sources of bleeding in the chest or abdomen when other tests are inconclusive.
Non‑Pharmacological Treatments for Anemia
Dietary Diversification
Eating a wide variety of iron-rich foods—such as lean meats, beans, and leafy greens—helps ensure you get both heme and non‑heme iron. A diversified diet not only provides iron but also vitamin C and other nutrients that improve iron absorption and support red blood cell production World Health OrganizationNCBI.Food Fortification
Adding iron, folic acid, and vitamin B12 to staple foods like flour and rice at the national level increases population-wide nutrient intake and reduces anemia rates by ensuring daily consumption of essential micronutrients IRISWHO Apps.Home Micronutrient Powder (MNP) Fortification
Sprinkling micronutrient powders onto home‑prepared foods delivers small doses of iron, zinc, and vitamins with each meal. This targeted approach raises individual micronutrient intake and improves hemoglobin levels without changing dietary habits drastically PubMedIRIS.Biofortification of Crops
Breeding staple crops—such as beans and rice—to naturally contain more iron and zinc provides sustainable improvements in dietary micronutrient intake and helps communities that rely heavily on these staples WHO Apps.Cooking with Cast‑Iron Cookware
Cooking acidic foods (e.g., tomato sauce) in cast‑iron pots releases iron into the food, increasing dietary iron intake by 1.5 to 3.3 times compared with non‑iron cookware, which can significantly improve hemoglobin levels over time PubMedNCBI.Use of Iron‑Releasing Cooking Ingot (Lucky Iron Fish)
Placing a small iron ingot in boiling water or soups releases bioavailable iron into meals. This simple practice provides up to 75% of the recommended daily iron intake and has been shown to raise hemoglobin in iron‑deficient individuals Wikipedia.Delayed Cord Clamping
Waiting 1–3 minutes before clamping the umbilical cord after birth allows more blood to transfer from placenta to newborn, increasing neonatal iron stores and reducing the risk of anemia in the first six months of life PMCWorld Health Organization.Deworming Programs
Regular administration of anti‑helminthic medications in areas with high parasitic worm prevalence prevents intestinal blood loss and iron loss, significantly reducing anemia in school‑aged children PMCWorld Health Organization.Malaria Prevention and Treatment
Distributing insecticide‑treated bed nets and prompt antimalarial therapy minimizes malaria‑induced hemolysis, which is a major cause of anemia in endemic regions PMCWorld Health Organization.Water, Sanitation, and Hygiene (WASH) Improvements
Providing clean water and promoting hygiene reduces diarrheal diseases and parasitic infections that impair nutrient absorption and cause chronic blood loss World Health OrganizationWorld Health Organization.Nutrition Education Programs
Community‑based education on iron‑rich diets, meal planning, and absorption enhancers empowers families to make sustainable dietary changes that prevent anemia PubMed.Social and Behavior Change Communication
Mass media campaigns and counseling encourage adherence to anemia prevention practices—such as taking prenatal supplements and dietary adjustments—leading to measurable declines in anemia prevalence World Health Organization.Family Planning and Birth Spacing
Allowing at least 24 months between pregnancies gives mothers time to replenish iron stores, reducing maternal anemia and related complications World Health Organization.Management of Heavy Menstrual Bleeding
Non‑drug approaches—such as uterine balloon tamponade in acute bleeding—help control menstrual loss, preventing iron depletion in women of reproductive age PMCPMC.Preventive Vaccination and Infection Control
Immunizations against diseases like measles, which can cause anemia, and prompt treatment of infections limit anemia related to immune activation and blood cell destruction World Health OrganizationWorld Health Organization.Screening and Management of Chronic Diseases
Early detection and treatment of gastrointestinal disorders, chronic kidney disease, and inflammatory conditions prevent chronic blood loss and malabsorption that lead to anemia World Health Organization.Nutrition Rehabilitation for Malnourished Children
Therapeutic feeding programs with micronutrient‑fortified foods restore iron and other nutrient stores in severely undernourished children, significantly improving hemoglobin IRIS.Iron‑Rich School Meal Programs
Providing fortified school lunches with iron and vitamin C enhances iron intake during critical growth periods, reducing anemia rates among students IRIS.Community‑Based Iron Supplementation Campaigns
Periodic distribution of iron and folic acid tablets in high‑risk groups—such as adolescent girls—bolsters iron stores and lowers anemia prevalence PubMed.Home Gardening and Crop Diversification
Growing iron‑rich vegetables and legumes at home increases access to fresh, nutrient‑dense foods, supporting long‑term anemia prevention World Health Organization.
Pharmacological Treatments (Drugs)
Ferrous Sulfate (325 mg PO once or twice daily)
Ferrous Gluconate (240 mg PO once daily)
Ferrous Fumarate (300 mg PO once daily)
Class: Oral iron salt
Purpose: High elemental iron content for severe deficiency
Time: On an empty stomach with vitamin C for best absorption
Side Effects: Diarrhea, epigastric pain .
Iron Polysaccharide Complex (150 mg PO daily)
Iron Sucrose (200 mg IV over 2 hours, 5 × weekly)
Ferric Carboxymaltose (750 mg IV once weekly)
Class: Intravenous iron
Purpose: Single or two‑dose correction of iron deficiency
Time: IV infusion over 15 minutes
Side Effects: Headache, flushing Wikipedia.
Iron Dextran (100 mg IV over 1 hour, repeated 10–20 days)
Class: Intravenous iron
Purpose: For severe anemia when oral therapy fails
Time: IV infusion with test dose
Side Effects: Anaphylaxis (rare), arthralgia Medscape ReferencePubMed.
Erythropoietin Alfa (50–100 IU/kg SC or IV 3× weekly)
Darbepoetin Alfa (0.45 μg/kg SC weekly or 500 μg SC every 3 weeks)
Class: ESA
Purpose: Longer‑acting erythropoiesis stimulation in CKD and cancer
Time: Weekly or every 3 weeks
Side Effects: Cardiovascular events, tumor progression risk Medscape ReferenceWikipedia.
Methoxy Polyethylene Glycol‑Epoetin Beta (6 μg/kg SC every 2 weeks or 12 μg/kg monthly)
- Darbepoetin Alfa (Aranesp)
Dosage: 0.45 µg/kg SC every week or 0.75 µg/kg every two weeks.
Class: Long-acting ESA.
Timing: Weekly or biweekly.
Side Effects: Similar to epoetin alfa.
Vitamin B₁₂ (Cyanocobalamin)
Dosage: 1,000 µg IM daily for one week, then weekly for four weeks, then monthly.
Class: Water-soluble vitamin.
Timing: Intramuscular injections.
Side Effects: Rare; injection discomfort.
Folic Acid (Folate)
Dosage: 1 mg orally once daily.
Class: B-vitamin.
Timing: Daily with or without food.
Side Effects: Generally well tolerated.
Pentoxifylline (Trental)
Dosage: 400 mg orally three times daily.
Class: Hemorheologic agent.
Timing: With meals to reduce GI upset.
Side Effects: Dizziness, nausea, headache.
Leucocyte-Poor Packed Red Blood Cells
Dosage: 1 unit over 2–4 hours, may repeat as needed.
Class: Blood product.
Timing: Transfusion when hemoglobin < 7 g/dL or symptomatic.
Side Effects: Transfusion reactions, iron overload.
Comparison of intravenous iron preparations available in the USA.
| Iron dextran | Iron sucrose | Sodium ferric gluconate | Ferumoxytol | |
|---|---|---|---|---|
| Infusion dose | 100 mg | 100 mg | 125 mg | 510 mg |
| Test dose required | Yes | No | No | No |
| Rate of injection* | 100 mg given over 2 min (50 mg/min) | 100 mg given over 2–5 min (20–50 mg/min) | 125 mg given over 10 min (12.5 mg/min) | 510 mg given over 17 s (30 mg/s) |
| Rate of infusion (in 0.9% NaCl)* | Not FDA approved | 100 mg/100 ml 0.9% NaCl given over 15 min | 125 mg/100 ml 0.9% NaCl over 1 h | Not FDA approved |
*Injection/infusion rates are based on studies in hemodialysis dependent-chronic kidney disease patients. FDA, US Food and Drug Administration.
The formula to calculate iron requirement to replete iron stores in adults.
| Formula |
| Elemental iron (mg) = 50 × [0.442 (desired Hgb g/L minus observed Hgb g/L) × lean body weight (see below for men and women) + 0.26 × lean body weight] |
| Lean body weight |
| For men: lean body weight = 50 kg + 2.3 kg for each inch in height over 60 inches |
| For women: lean body weight = 45.5 kg + 2.3 kg for each inch in height over 60 inches |
| Note: use actual body weight if lean body weight is less than actual weight. |
| Intravenous iron preparations (mg elemental iron/ml) |
| Iron dextran = 50 mg |
| Iron sucrose: = 20 mg |
| Sodium ferric gluconate = 12.5 mg |
| Ferumoxytol = 30 mg |
| The formula was derived from: iron dextran injection calculator by David McAuley, GlobalRPh http://www.globalrph.com/irondextran.htm with permission |
Intravenous Iron Preparations
| Iron Formulation | Test Dose | Dose Per Session a |
|---|---|---|
| High-molecular-weight iron dextran | 25 mg (0.5 mL) over 5 minutes, monitor 1 hour | 100 mg of iron intravenously at <50 mg/min |
| Low-molecular-weight iron dextran | 25 mg (0.5 mL) over 30 seconds, monitor 1 hour | 100 mg of iron intravenously at <50 mg/min |
| Ferric carboxymaltose | No | 750 mg of iron intravenously at 100 mg/min or infusion over 15 minutes. For patients weighing <50 kg (110 lb), maximum of 15 mg of iron per kilogram of body weight |
| Ferumoxytol | No | 510 mg of iron intravenously at 30 mg/s or infusion over 15 minutes |
| Iron sucrose | No | 100-200 mg intravenously over 2-5 minutes or infusion over 15 minutes |
| Sodium ferric gluconate complex | No | 62.5-125 mg intravenously at 12.5 mg/min or infusion over 1 hour |
- Oral iron supplements are the best way to restore iron levels for people who are iron deficient, but they should be used only when dietary measures have failed. However, iron supplements cannot correct anemias that are not due to iron deficiency.
- Iron replacement therapy can cause gastrointestinal problems, sometimes severe ones. Excess iron may also contribute to heart disease, diabetes, and certain cancers. Doctors generally advise against iron supplements in anyone with a healthy diet and no indications of iron deficiency anemia.
- Treatment of Anemia of Chronic Disease. In general, the best treatment for anemia of chronic diseases is treating the disease itself. In some cases, iron deficiency accompanies the condition and requires iron replacement. Erythropoietin, most often administered with intravenous iron, is used for some patients.
Oral Iron Supplement
- Supplement Forms. There are two forms of supplemental iron: ferrous and ferric. Ferrous iron is better absorbed and is the preferred form of iron tablets. Ferrous iron is available in three forms: ferrous fumarate, ferrous sulfate, and ferrous gluconate.
- The label of an iron supplement contains information both on the tablet size (which is typically 325 mg) and the amount of elemental iron contained in the tablet (the amount of iron that is available for absorption by the body.) When selecting an iron supplement, it is important to look at the amount of elemental iron.
A 325 mg iron supplement contains the following amounts of elemental iron depending on the type of iron:
- Ferrous fumarate. 108 mg of elemental iron
- Ferrous sulfate. 65 mg of elemental iron
- Ferrous gluconate. 35 mg of elemental iron
Dosage. Depending on the severity of your anemia, as well as your age and weight, your doctor will recommend a dosage of 60 – 200 mg of elemental iron per day. This means taking one iron pill 2 – 3 time during the day. Make sure your doctor explains to you how many pills you should take in a day and when you should take them. Never take a double dose of iron.
Intravenous or Injected Iron
In some cases, iron is administered through muscular injections or intravenously. Intravenous iron has the advantage of causing less gastrointestinal discomfort and inconvenience. It may be in the form of iron dextran (Dexferrum, InFed), sodium ferric gluconate complex in sucrose (Ferrlecit), or iron sucrose (Venofer). Ferrlecit or Venofer are proving to be at least equally effective and safer than iron dextran.
Candidates. The injected or intravenous forms should be limited to the following patients with iron deficiency:
- People with iron deficiency anemia in whom oral therapy has clearly failed.
- Patients with bleeding disorders in which blood loss continues to exceed the rate at which oral iron is absorbed.
- In emergencies, when people need red blood cells but transfusion is not appropriate or available.
- In people with serious gastrointestinal disorders, such as inflammatory bowel disease, who cannot take iron therapy by mouth.
- People undergoing hemodialysis who receive supplemental erythropoietin therapy. Sodium ferric gluconate complex in sucrose (Ferrlecit) or iron sucrose (Venofer) is specifically approved as first-line therapy for these patients.
Certain patients, even if they meet these qualifications, may not be appropriate candidates or should be monitored closely for complications. They include:
- Patients with any underlying autoimmune disease.
- Malnourished patients who also have an underlying infection.
- Patients who are at risk for iron overload.
Side Effects. Some side effects differ depending on how the iron is administered and include the following:
- Muscular injections include pain at the site.
- Intravenous administration can cause pain in the vein, flushing, and metallic taste, all of which are brief.
For both methods, side effects and serious complications can include:
- Blood clots
- Fever
- Joint aches
- Headache
- Rashes
- A delayed reaction of joint and muscle aches, headache, and malaise occurs 1 – 2 days after the infusion (most commonly with iron dextran) in about 10% of patients. These symptoms respond quickly to NSAIDs, such as ibuprofen or naproxen, in most people.
- Iron toxicity. Symptoms include nausea, dizziness, and a sudden drop in blood pressure. Sodium ferric gluconate in sucrose (Ferrlecit) or iron sucrose (Venofer) may pose a lower risk for toxicity than iron dextran.
- Allergic reactions. Allergic reactions that occur with intravenous iron can be very serious and, in rare cases, even fatal. Iron dextran appears to pose a much higher risk than sodium ferric gluconate complex in sucrose or iron sucrose, although allergic reactions can also occur with the latter forms.
Oral and injected iron should never be given at the same time. Intravenous iron therapy may be appropriate for some pregnant women who meet these requirements, depending on the pregnancy term and other factors.
Blood Transfusions
- Transfusions are used to replace blood loss due to injuries and during certain surgeries. They are also commonly used to treat severely anemic patients who have thalassemia, sickle cell disease, myelodysplastic syndromes, or other types of anemia. Some patients require frequent blood transfusions. Iron overload can be a side effect of these frequent blood transfusions. If left untreated, iron overload can lead to liver and heart damage.
- Iron chelation therapy is used to remove the excess iron caused by blood transfusions. Patients take a drug that binds to the iron in the blood. The excess iron is then removed from the body by the kidneys. For many years, deferoxamine (Desferal) was the only drug used in chelation therapy. This drug is usually injected intravenously, using an infusion pump. The infusion can last 8 – 12 hours and may be needed 5 – 7 days a week until iron levels are normal.
- A new drug, deferasirox (Exjade), was approved in 2005 for children and adults as a once-daily treatment for iron overload due to blood transfusions. It does not require injections. Patients mix the deferasirox tablets in liquid and drink the medicine. However, deferoxamine can cause gastrointestinal tract ulcerations and hemorrhage and patients should be carefully monitored. Deferoxamine can interact with certain types of medications such as nonsteroidal anti-inflammatory drugs, corticosteroids, bisphosphonates, and anticoagulants.
Erythropoiesis Stimulating Drugs
- Erythropoietin is the hormone that acts in the bone marrow to increase the production of red blood cells. It has been genetically engineered as recombinant human erythropoietin (rHuEPO) and is available as epoetin alfa (Epogen, Procrit, and Eprex). Novel erythropoiesis stimulating protein (NESP), also called darbepoetin alfa (Aranesp), lasts longer in the blood than epoetin alfa and requires fewer injections. These medications are also called “erythropoiesis-stimulating drugs.”
- Levels of erythropoietin are reduced in anemia of chronic disease. Injections of synthetic erythropoietin can help increase the number of red blood cells in order to avoid receiving blood transfusions. Erythropoietin is used to treat anemia. It does not help improve anemia symptoms, fatigue, or quality of life for patients with cancer or HIV. This drug can cause serious side effects, including blood clots, and is approved only for treating patients with anemia related to the following conditions:
- Cancer. For select patients, erythropoietin is used to treat the anemia associated with chemotherapy.
- Chronic kidney failure. Erythropoietin is an important anemia treatment for patients with chronic kidney failure, including those on dialysis.
- HIV/AIDS. Erythropoietin helps treat the anemia caused by zidovudine (AZT) therapy.
- Erythropoiesis-Stimulating Drugs and Cancer. Erythropoietin should be used only to treat anemia caused by chemotherapy — not anemia due to other causes in patients with cancer. Erythropoietin treatment does not help prolong survival. In fact, these drugs can shorten survival time and cause tumors to grow faster. Discuss with your doctor whether an erythropoiesis-stimulating drug is appropriate for you.
- Survival and tumor growth risks are especially pronounced for patients with advanced breast, head and neck, lymphoid, or non-small cell lung cancer when dosing attempts to achieve a hemoglobin level of 12 g/dL or greater. However, there may be similar risks for patients dosed to less than 12 g/dL. (The American Society of Clinical Oncology and the American Society of Hematology recommend starting erythropoietin when a patient’s hemoglobin level falls to less than 10 g/dL.) The doctor should use the lowest effective dose and erythropoietin treatment should be stopped as soon as the chemotherapy course is completed.
- Erythropoiesis-Stimulating Drugs and Chronic Kidney Failure. For patients with chronic kidney failure, the FDA recommends that erythropoiesis-stimulating drugs be used to maintain hemoglobin levels between 10 – 12 g/dL. (The exact level within this range varies by individual.) There is a greater risk of death and serious cardiovascular events, such as heart attack, stroke, and heart failure when these drugs are used to achieve higher hemoglobin levels (13.5 – 14g/dL) compared to lower hemoglobin levels (10- 11.3 g/dL).
In 2007, the Food and Drug Administration (FDA) made major changes to the prescribing information for erythropoiesis-stimulating drugs. The new labels describe in detail the risks that Aranesp, Epogen, and Procrit can pose to patients with cancer and chronic kidney disease. The FDA has also established separate dosing recommendations for each of these conditions.
Dietary Molecular Supplements
Vitamin C (Ascorbic Acid) – 500 mg daily enhances iron absorption by converting ferric to ferrous iron and counteracting inhibitors like phytates NCBIPMC.
Folic Acid – 400 μg daily supports DNA synthesis in red blood cell precursors; prevents megaloblastic changes PubMedMayo Clinic.
Vitamin B12 (Cobalamin) – 1,000 μg monthly IM or 1,000 μg daily PO corrects pernicious anemia by restoring DNA methylation pathways PubMedMayo Clinic.
Vitamin A – 10,000 IU daily improves iron mobilization from stores and enhances erythropoiesis PubMedWorld Health Organization.
Copper – 2 mg daily acts as a cofactor for ceruloplasmin, aiding iron oxidation and transport PubMedPMC.
Zinc – 15 mg daily supports hematopoietic stem cell function and immunity PubMedWorld Health Organization.
Vitamin D – 2,000 IU daily modulates erythropoietin sensitivity and reduces inflammation PubMedWorld Health Organization.
Probiotics – daily blends improve gut health and nutrient absorption, including iron World Health Organization.
Lipid‑Based Nutrient Supplements – sachets for children contain iron, zinc, and vitamins for catch‑up growth and anemia prevention PubMedIRIS.
Ferritin‑Rich Foods (e.g., legumes, algae) – 1 cup daily provides both iron and its storage protein form for improved bioavailability .
Regenerative and Stem‑Cell‑Targeted Drugs
Erythropoietin (Epoetin Alfa) – 50–100 IU/kg SC 3× weekly; binds Epo receptor on progenitors to stimulate RBC production NCBIWikipedia.
Darbepoetin Alfa – 0.45 μg/kg weekly; glycosylated ESA with prolonged half‑life stimulates erythropoiesis Medscape ReferenceWikipedia.
Methoxy Polyethylene Glycol‑Epoetin Beta (CERA) – 6 μg/kg SC every 2 weeks or 12 μg/kg monthly; extended receptor activation for CKD anemia PMCWikipedia.
Roxadustat – 70–100 mg PO 3× weekly; HIF‑PHD inhibitor that increases endogenous EPO and improves iron utilization WikipediaPMC.
Daprodustat – 2–48 mg PO 3× weekly; HIF‑PHD inhibitor enhancing erythropoietin production and iron metabolism PMCPMC.
Vadadustat – 300 mg PO daily; HIF‑PHD inhibitor that stimulates EPO and reduces hepcidin to boost red cell formation Medscape ReferencePubMed.
Advanced therapies to support marrow recovery and immunity.
Filgrastim (G-CSF)
Dosage: 5 µg/kg SC daily.
Function: Increases neutrophils, indirectly supporting overall marrow health.
Mechanism: Stimulates granulocyte colony-forming units.
Plerixafor (Mozobil)
Dosage: 0.24 mg/kg SC single dose.
Function: Mobilizes stem cells into blood for collection.
Mechanism: CXCR4 antagonist releasing CD34+ cells.
Eltrombopag (Promacta)
Dosage: 50 mg orally daily.
Function: Thrombopoietin receptor agonist; may boost red cell precursors.
Mechanism: Activates JAK-STAT pathway in progenitor cells.
Luspatercept (Reblozyl)
Dosage: 1 mg/kg SC every three weeks.
Function: Enhances late-stage erythroblast maturation.
Mechanism: Binds TGF-β superfamily ligands to reduce Smad2/3 signaling.
Bone Morphogenetic Protein 2 (BMP-2)
Dosage: Used locally during surgery.
Function: Stimulates mesenchymal stem cells.
Mechanism: Induces osteogenic and erythropoietic growth factors.
Thymosin α1
Dosage: 1.6 mg subcutaneously twice weekly.
Function: Modulates T-cell activity, supporting immune-mediated marrow recovery.
Mechanism: Enhances dendritic cell maturation and cytokine release.
Surgical and Procedural Treatments
Splenectomy
Partial Splenectomy
Allogeneic Bone Marrow (Hematopoietic Cell) Transplant
Endometrial Ablation
Uterine Artery Embolization (UAE)
Hysteroscopic Myomectomy
Procedure: Removal of submucosal fibroids via a thin scope inserted through the cervix
Benefits: Targets bleeding fibroids, reduces anemia, and preserves fertility PMC.
Hysterectomy
Partial Splenic Artery Embolization (PSE)
Selective Splenic Artery Embolization (SSAE)
Procedure: Targeted coil embolization for refractory autoimmune hemolytic anemia
Benefits: Lifesaving in high‑risk patients not eligible for surgery, with rapid hematologic response PubMed.
Blood Transfusion (Red Cell Transfusion)
Procedure: Intravenous infusion of packed red blood cells
Benefits: Immediate correction of severe anemia (Hb <7 g/dL or symptomatic), stabilizing patients for further treatment Mayo Clinic.
Prevention Strategies
Prenatal Iron and Folic Acid Supplementation World Health OrganizationPubMed
Deworming in High‑Risk Areas PMCWorld Health Organization
Malaria Prevention (Nets & Treatment) PMCWorld Health Organization
Delayed Cord Clamping at Birth PMCWorld Health Organization
Improved Water, Sanitation, and Hygiene (WASH) World Health OrganizationWorld Health Organization
Nutrition Education & Behavior Change PubMed
Family Planning & Birth Spacing World Health Organization
Management of Heavy Menstrual Bleeding Wikipedia
Early Screening for Chronic Disease and GI Bleeding World Health Organization
When to See a Doctor
You should consult a healthcare professional if you experience persistent symptoms such as extreme fatigue, dizziness, rapid heartbeat, shortness of breath, pale skin, or unusual cravings (pica). Iron deficiency anemia is not a condition to self‑treat, as excess iron can be toxic; proper diagnosis and tailored therapy based on laboratory tests are essential Mayo ClinicMayo Clinic.
Foods to Eat and Foods to Avoid
Foods to Eat
Lean Red Meat – High in bioavailable heme iron; supports quick iron repletion NCBI.
Poultry and Fish – Good heme iron sources and rich in protein for red cell formation NCBI.
Legumes and Beans – Provide plant‑based iron plus protein and fiber; pair with vitamin C to boost absorption NCBI.
Dark Leafy Greens (e.g., spinach, kale) – Contain non‑heme iron and folate; rich in antioxidants NCBI.
Nuts and Seeds – Sources of iron, healthy fats, and trace minerals; snack on sunflower seeds, almonds, or pumpkin seeds NCBI.
Foods to Avoid or Limit
Tea and Coffee at Meals – Polyphenols bind iron and block its absorption; wait at least 1 hour after eating NCBI.
Dairy with Meals – Calcium interferes with both heme and non‑heme iron absorption; consume between meals NCBI.
High‑Phytate Foods during Iron‑Rich Meals (e.g., unsoaked whole grains, legumes) – Phytates form insoluble complexes with iron; soak or ferment grains to reduce phytate content PMC.
Soy Products – Soy protein contains inhibitors that reduce non‑heme iron uptake; pair with vitamin C or use sparingly at meals PMC.
Egg Whites with Iron‑Rich Foods – Egg proteins can inhibit iron absorption; avoid serving eggs with iron supplements or high‑iron meals PMC.
What foods are high in iron?
The following foods are good sources of iron:
- Oysters
- Kidney beans
- Beef liver
- Tofu
- Beef (chuck roast, lean ground beef)
- Turkey leg
- Whole wheat bread
- Tuna
- Eggs
- Shrimp
- Peanut butter
- Leg-of-lamb
- Brown rice
- Raisin bran (enriched)
- molasses


